2: Herpes Flashcards

(50 cards)

1
Q

herpes simplex virus (HSV) is the leading cause of _____

A

infectious corneal blindness in all developed countries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

HSV is categorized by _____, and further categorized by _____

A

viral strand;

infection- primary or recurrent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

primary HSV-1 transmission

A
  • mucosal membranes
  • saliva
  • tears
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

primary HSV-1 is highly ______;

____% of population get it by age 5, and _____% by age 60

A

contagious;
60;
~100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

primary HSV-1 most common patient populations

A

school-aged children** and neonates (rare)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

primary HSV-1 has a more severe presentation in _____

A

neonates and immunocompromised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

primary HSV-1 symptoms are _____;

symptoms include:

A

RARE (~94% of patients are asymptomatic);

  • flu-like malaise
  • low-grade fever
  • possible concurrent upper respiratory infection
  • oropharynx > ocular
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

primary HSV-1 ocular clinical signs

A
  • pre-auricular node swelling
  • vesicular rash (eyelids and adnexa)
  • follicular conjunctivitis
  • rare: multiple corneal punctate lesions –> coalesce into epithelial dendrite
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

primary HSV-1: epithelial vesicles

A
  • contain the live virus

- primary HSV-1 vesicles are limited to the epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

after active infection, primary HSV-1 lies latent in the _____

A

trigeminal and dorsal root ganglia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

recurrent HSV-1 transmission

A
  • mucosal membranes
  • saliva
  • tears
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

recurrent HSV-1 has more severe presentation in _____

A

children and immunocompromised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

recurrent HSV-1 laterality

A

unilateral&raquo_space; bilateral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ocular involving recurrent HSV-1 is also known as _____

A

Herpes Simplex Keratitis (HSK)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ocular involving recurrent HSV-1 (HSK) symptoms

A
  • pain/ocular discomfort
  • photophobia
  • watering
  • itching
  • decreased vision/blurry vision
  • corneal desensitization (hypoesthesia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ocular involving recurrent HSV-1 (HSK) signs

A
  • pre-auricular node swelling
  • vesicular rash (eyelids and adnexa)
  • follicular conjunctivitis
  • dendritic keratitis**
  • conjunctival injection
  • superficial macropunctate keratitis (larger punctate areas than classic SPK)
  • other anterior and posterior complications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

ocular involving recurrent HSV-1 (HSK): adnexal and eyelid vesicles

A

clear vesicles on an erythematous base that progress to crusting (more itchy than painful)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

ocular involving recurrent HSV-1 (HSK): corneal types of HSK

A

HSK-epithelial:

  • dendritic
  • geographic
  • neurotrophic
  • marginal

HSK-stromal:

  • disciform (also is endothelial)
  • immune
  • necrotizing

Endotheliitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

HSK-epithelial: dendritic keratitis

A
  • pathognomonic herpetic finding
  • ulceration of the epithelium with underlying stromal thinning
  • heaped, swollen epithelial cells create boundary and terminal end-bulbs
  • branching/arborized appearance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

HSK-epithelial: dendritic keratitis staining

A
  • (+) stain with fluorescein in center

- (+) stain with fluoroscien (mild), rose bengal, lissamine green along boundary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

HSK-epithelial: dendritic keratitis left unmanaged

A

unmanaged –> corneal haze, stromal infiltration –> scarring

22
Q

HSK-epithelial: geographic keratitis

A
  • dendritic may progress to geographic

- swollen, scalloped borders

23
Q

HSK-epithelial: neurotrophic keratitis

A
  • sterile ulcer
  • typically in tandem with interstitial (necrotizing) keratitis
  • stromal melt and corneal perforation –> “endophthalmitis”
  • corneal degradation –> desnsitization –> “I got better!”
  • vision threatening
24
Q

HSK-epithelial: marginal/limbal keratitis

A
  • active virus + inflammatory reaction

- peripheral ulcer –> stromal infiltrate –> limbal/corneal neo

25
HSK-stromal: disciform keratitis
- non-necrotizing (does not degrade the corneal tissue), immune response to residual herpetic proteins --> inflammation - opaque or "ground glass", disc shaped stromal and endothelial infiltration with stromal and endothelial edema - can occur concomitantly with HSK-epithelial, can occur after HSK-epithelial
26
HSK-stromal: immune, stromal keratitis (SK)
- non-necrotizing stromal keratitis, aka "stromal keratitis" - round/lobulated opaque/whitened stromal infiltration (haze and scarring) - can occur concomitantly with HSK-epithelial, can occur after HSK-epithelial
27
HSK-stromal: necrotizing, interstitial keratitis (IK)
- less common, more severe - white/gray opaque stromal infiltration with necrosis and ulceration, stromal edema, possible abscess, corneal neovascularization - may also have concomitant uveitis, hypopyon, trabeculitis (inflammatory increase in IOP) - unmanaged IK --> neurotrophic ulcer, corneal perforation - high risk of vision loss
28
HSK-endothelial: endotheliitis
- endothelial keratitis - typically in tandem with HSK-stromal involvement, especially disciform - presents with endothelial folds, endothelial edema, stromal edema, may include keratic precipitates - concomitant uveitis, trabeculitis (increased IOP) - high risk of vision loss
29
recurrent HSV-1 (HSK) complications
- corneal hypoesthesia (especially with corneal involvement) - uveitis: anterior, intermediate, posterior, panuveitis; typically in tandem with SK, IK, or endotheliitis; AC rxn (mild to severe), granulomatous KPs, elevated IOP; iris atrophy, posterior synechiae, secondary angle closure (trabeculitis) - scleritis > episcleritis - retinitis, acute retinal necrosis (ARN): neonates, immunocompromised, concurrent HIV/AIDS infection; severe, bilateral, rapid progression - optic neuritis: optic nerve edema, typically in tandem with retinal necrosis
30
varicella zoster virus (VZV) categorization
categorized by infection: primary or recurrent
31
primary VZV
- chicken-pox - childhood condition - largely declined since introduction of the varicella vaccination in 1995
32
recurrent VZV
- shingles - elderly > adult condition - can occur at any age, but typically 60-80 years
33
VZV laterality
ALWAYS unilateral*
34
after primary infection, VZV lies dormant in ____
trigeminal ganglion
35
3 stages of reactivated VZV
1) prodrome (pre-eruptive) 2) active virus outbreak (acute eruptive, active HZO) 3) post-herpetic neuralgia (chronic neuropathy)
36
reactivated VZV prodrome symptoms
more common: - headache - fever - malaise - bodily tingling, burning, pain - blurred vision, ocular irritation, photophobia less common: - moodiness - depression - insomnia *prodrome symptoms may carry over with the active viral outbreak
37
reactivated VZV outbreak
- aka: shingles - erythematous rash --> erupts into crusty, scaly vesicular lesions; follows trigeminal dermatome pattern; ALWAYS respects facial midline*; may involve scalp, face, ear, neck, torso, arms, legs; intensely painful! - Hutchinson's sign: vesicular eruptions on tip of the nose; still respects facial midline; signals nasociliary nerve involvement --> higher risk of ocular involvement - ocular complications (HZO)
38
herpes zoster ophthalmicus (HZO)
- 10-20% of all shingles patients - VZV reactivation along the ophthalmic branch of the trigeminal nerve; HZO linked to weakening T-cell immunity of elderly and immunocompromised pts
39
herpes zoster ophthalmicus (HZO) symptoms and signs
- blurred vision - ocular irritation - photophobia - redness - tearing - painful unilateral vesicular rash (look at scalp, forehead, ear, behind ear, adnexa, eyelids, cheek, nose) - periorbital edema - ptosis (from edema) - corneal involvement
40
herpes zoster ophthalmicus (HZO) corneal involvement
- pseudodendrite* - superficial punctate keratitis (SPK) - disciform stromal keratitis, immune stromal keratitis (SK), necrotizing/interstitial keratitis (IK), endotheliitis - neurotrophic ulcer - neovascularization, corneal thinning, corneal opacification
41
pseudodendrite
- elevated mucosal plaque, "painted on" appearance - not a true epithelial ulcer - less vibrant/less complete staining with fluorescein - expect minimal to no rose bengal or lissamine green staining - no terminal endbulbs; tapered lines - may also present with filaments
42
VZV/HZO complications
- uveitis: anterior, intermediate, posterior, panuveitis; AC rxn (mild to severe), granulomatous KPs; iris atrophy, posterior synechiae, trabeculitis --> increased IOP - scleritis: anterior and posterior - retinitis/choriditis: slight increased predilection to involve choroid over HSV - optic neuritis - brain and orbit: CVA/ischemic damage; orbital apex syndrome
43
orbital apex syndrome
- paralysis of CN II, III, IV, VI, ophthalmic branch of CN V - optic nerve atrophy, permanent visual loss even with restoration of EOM movement and reduction of orbital inflammation with systemic steroids
44
post-herpetic neuralgia (PHN)
- develops if recurrent VZV is unmanaged - ~72 hour window to initiate appropriate treatment - severely painful nervous condition - can last months to years post active infection - #1 cause of suicide in patients with chronic pain >70 years old
45
VZV prevention
- varicella vaccine: "chicken-pox" vaccine, 1995 - Zostavax: 2006, no longer vaccination of choice for shingles - Shingrix: 2017, proven greater efficacy than Zostavax at shingles prevention - reduced risk of VZV complications - 90% effectivity in prevention of shingles AND PHN ages 50-70 - 85% for 70+ - approved for 50+ - 2 doses separated by 2-6 months - not approved for immunocompromised or those receiving chemo/radiation - may receive even if had Zostavax vaccine previously - may receive if had shingles previously, just not during active infection
46
oral antiviral doses for HSK
- acyclovir: 400 mg 5x/day PO x7-10 days - valacyclovir: 500 mg tid PO x7-10 days - famciclovir: 250 mg tid PO x7-10 days
47
oral antiviral doses for VZV/HZO
- acyclovir: 800 mg 5x/day PO x7-10 days - valacyclovir: 1000 mg tid PO x7-10 days - famciclovir: 500 mg tid PO x7-10 days
48
oral antivirals for prophylaxis
- acyclovir: 400 mg bid - valacyclovir: 500 mg qd - famciclovir: 250 mg bid
49
reasons for prophylaxis tx of herpes
- multiple recurrences of any type of HSV keratitis, especially HSV stromal keratitis - recurrent inflammation with scar/vascularization approaching visual axis - more than one episode of HSV keratitis with ulceration - post-keratoplasty performed for HSV-related scarring/astigmatism - postoperatively in patients with a history of HSV ocular disease undergoing any type of ocular surgery or laser procedure - in patients with a history of HSV during immunosuppressive treatment
50
intravenous antivirals for herpes
- for immunocompromised or sight threatening disease | - more common for posterior segment complications or patients with concurrent HIV/AIDS, CMV